Skip to the briefing San Tan Valley / Put Arizona credentials first Questions for an Arizona prescriber Evidence brief / Names and proof Make sense of the medicine’s claim. Ask for evidence about the product being proposed and the reason for using it. The word “peptide” alone cannot answer that. Ask which product was reviewed Knowing an ingredient’s name gives you a place to start. Get the full product name, then ask how it is taken: by tablet, by injection or another way. When a medicine is prepared to suit one patient’s particular need, that is compounding. FDA, short for Food and Drug Administration, is the U.S. agency responsible for reviewing medicines. A compounded medicine has no FDA approval, even if a medicine with that ingredient has been approved, as checked September 26, 2026. Custom preparations have a separate place A custom preparation may matter when a ready-made product cannot meet the patient’s need. Made-to-order medicines can be legal if the pharmacy and ingredient rules are met, as checked September 26, 2026. This does not allow a pharmacy to use any ingredient it chooses. For pharmacies using section 503A, a federal rule for made-to-order medicines, the raw ingredient has to meet one of three tests: If official drug-quality standards exist for it, it must meet those standards and the pharmacy-compounding standards. If the ingredient has no such standards, it must be used as an ingredient in an approved medicine. Where neither of those tests applies, the ingredient must appear on the federal list of permitted raw ingredients. The ingredient also needs a document showing its test results and must come from a maker recorded with FDA. Ask the pharmacist: “Which rule allows this ingredient, and how have you checked it?” Meeting an ingredient rule alone does not settle every rule for the medicine. Before a compounded product goes on sale, FDA does not review its quality, benefit and safety. Approved U.S. products exist for semaglutide (Ozempic, Wegovy) and for tirzepatide (Mounjaro, Zepbound), as of September 26, 2026. That approval does not carry over to a custom preparation bearing the ingredient’s name. FDA registration means a medicine business or facility is recorded with FDA. FDA registration gives no FDA approval to the business or its medicines, according to the federal rule checked September 26, 2026. Ask whether the evidence fits the claim What product was studied? Who took part? What was it compared with? Ask the person assessing your care to explain how the answer connects to your concern. FDA describes it as false or misleading to claim that compounded medicines are proved to match the results of approved products, as of September 26, 2026. Words that come up in a visit Peptide A substance consisting of a short row of small linked parts. Those parts also form proteins. One peptide you may know is insulin. FDA approval A review by the U.S. medicine regulator, the Food and Drug Administration, of a specific medicine and its stated uses. Compounding Preparation of a medicine to suit one patient’s particular need. Telehealth A care visit carried out from a distance, such as over video. Drug shortage A national supply shortage listed by FDA, rather than a pharmacy simply being out of stock. Prior authorization Your plan’s approval before it agrees to pay for the medicine. Adverse event An unwanted experience connected with a medical product’s use; reporting it alone cannot establish its cause. Read the claims worth questioning Open the official records FDA: custom preparations explained The role and limits of compounding. FDA: ingredients for compounding The three tests for ingredients under the federal pharmacy rule. FDA: semaglutide product label The reviewed product and its stated uses. FDA: tirzepatide product label The reviewed product and its stated uses. FDA: claims about custom medicines Claims FDA identifies as false or misleading. Federal rule: registration and listing Recording a business or medicine with FDA does not mean it has been approved. FDA: the national shortage list How a shortage differs from a local stock problem. FDA: how to read event reports Limits on what a report can establish. What would help right now? At a glance Begin with the care question. Find and check care Use the Arizona records. Your visit questions Get ready for the conversation. The whole cost Unpack the bill and coverage. The medicine and the proof Make sense of approval and claims. What to avoid Spot trouble and find urgent help. This guide gives you words for the care conversation; it operates no clinic and sells no medicine. Read this briefing in text